Some of them have had a large number of molecular tests performed, e.g., patient no. 15_17, who underwent MLPA and SNP microarray based on APEX technology for the OPA1 gene as well as the NGS panel encompassing the genes associated with autosomal dominant optic atrophy and the NGS panel for genetically determined retinal diseases (without the DNAJC30 gene included at that time). This evidence concerns the gene OPA1 and autosomal dominant optic atrophy.